Chugai Pharmaceutical
4519.T
#336
Rank
โ‚น6.968 T
Marketcap
โ‚น4,235
Share price
-0.22%
Change (1 day)
3.27%
Change (1 year)

Revenue for Chugai Pharmaceutical (4519.T)

Revenue in 2026 (TTM): โ‚น834.21 Billion

According to Chugai Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚น834.89 Billion. In 2025 the company made a revenue of โ‚น754.61 Billion an increase over the revenue in the year 2024 that were of โ‚น656.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Chugai Pharmaceutical from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น834.21 B10.55%
2025 โ‚น754.61 B15%
2024 โ‚น656.19 B0.27%
2023 โ‚น654.39 B-17.64%
2022 โ‚น794.53 B20.01%
2021 โ‚น662.05 B21.79%
2020 โ‚น543.61 B21.09%
2019 โ‚น448.92 B22.01%
2018 โ‚น367.94 B21.07%
2017 โ‚น303.91 B-1.53%
2016 โ‚น308.64 B12.35%
2015 โ‚น274.72 B1.9%
2014 โ‚น269.60 B2.43%
2013 โ‚น263.20 B0.46%
2012 โ‚น261.99 B5.22%
2011 โ‚น248.98 B26.1%
2010 โ‚น197.44 B-6.78%
2009 โ‚น211.81 B